May 19, 2020 / 02:00PM GMT
Matthew Charles Taylor - UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Great. Good morning, and welcome to our next session here at the UBS Virtual Healthcare Conference. In the med tech track, we have management from Baxter International. I'm really pleased to be joined by Jay Saccaro, the CFO of the company; and also Clare Trachtman, VP of Investor Relations. And today, we'll go over a number of topics on the different businesses and COVID.
Just one word of orientation for the session. If you have any questions, you can always e-mail me or send your questions in through the webcast. There'll be about a 40-minute Q&A.
So to start, I just want to thank Jay and Clare for joining us.
Questions and Answers:
Matthew Charles Taylor - UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & DevicesAnd Jay, maybe I'll kick it off to you with kind of a higher-level question. Talking about some of the shifting sands that we're seeing here. Baxter has